http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102498110-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2010-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f42a239eb21188d9c8e199155f178a90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e43266b6bfc798f95af78e37ebf5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd425caaf1eeed73bc8a68387000f6fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29848ece4bd8ad47b99480ecba69131a
publicationDate 2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102498110-A
titleOfInvention 2-(LH-pyrazol-4-ylamino)-pyrimidines as kinase inhibitors
abstract The present invention relates to a compound or a pharmaceutically acceptable salt of formula (I), Wherein A 1 , A 2 , A 3 , A 4 , X and Y are as defined in the specification. The invention also relates to methods of making said compounds, and compositions containing said compounds useful for inhibiting kinases such as Aurora and KDR.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015039613-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926824-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926794-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588885-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021078021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926824-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926794-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018086547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926795-A
priorityDate 2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008147831-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466896314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163617965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465237664

Total number of triples: 32.